BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37537659)

  • 41. A CT-based radiomics nomogram for predicting histopathologic growth patterns of colorectal liver metastases.
    Sun C; Liu X; Sun J; Dong L; Wei F; Bao C; Zhong J; Li Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9543-9555. PubMed ID: 37221440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiomic study on preoperative multi-modal magnetic resonance images identifies IDH-mutant TERT promoter-mutant gliomas.
    Wang H; Zhang S; Xing X; Yue Q; Feng W; Chen S; Zhang J; Xie D; Chen N; Liu Y
    Cancer Med; 2023 Feb; 12(3):2524-2537. PubMed ID: 36176070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study.
    Jiang Y; Zhang Z; Yuan Q; Wang W; Wang H; Li T; Huang W; Xie J; Chen C; Sun Z; Yu J; Xu Y; Poultsides GA; Xing L; Zhou Z; Li G; Li R
    Lancet Digit Health; 2022 May; 4(5):e340-e350. PubMed ID: 35461691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer.
    Yao X; Sun C; Xiong F; Zhang X; Cheng J; Wang C; Ye Y; Hong N; Wang L; Liu Z; Meng X; Wang Y; Tian J
    Eur J Radiol; 2020 Oct; 131():109205. PubMed ID: 32871292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study.
    Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Kokubo M; Negoro Y; Fushiki M; Ogura M; Itasaka S; Yamauchi C; Otsu S; Sakamoto T; Sakamoto M; Araki N; Hirashima H; Adachi T; Matsuo Y; Mizowaki T
    Med Phys; 2020 Sep; 47(9):4634-4643. PubMed ID: 32645224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A potential biomarker based on clinical-radiomics nomogram for predicting survival and adjuvant chemotherapy benefit in resected node-negative, early-stage lung adenocarcinoma.
    Ma X; Lv W; Wang C; Tu D; Qiao J; Fan C; Niu J; Zhou W; Liu Q; Xia L
    J Thorac Dis; 2022 Jan; 14(1):1-17. PubMed ID: 35242363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative Prediction of Microsatellite Instability in Colorectal Cancer With Preoperative PET/CT-Based Radiomics.
    Li J; Yang Z; Xin B; Hao Y; Wang L; Song S; Xu J; Wang X
    Front Oncol; 2021; 11():702055. PubMed ID: 34367985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Developing and validating ultrasound-based radiomics models for predicting high-risk endometrial cancer.
    Moro F; Albanese M; Boldrini L; Chiappa V; Lenkowicz J; Bertolina F; Mascilini F; Moroni R; Gambacorta MA; Raspagliesi F; Scambia G; Testa AC; Fanfani F
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):256-268. PubMed ID: 34714568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer.
    Liu Z; Guo C; Dang Q; Wang L; Liu L; Weng S; Xu H; Lu T; Sun Z; Han X
    EBioMedicine; 2022 Jan; 75():103750. PubMed ID: 34922323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer.
    Chen Y; Xu M; Ye Q; Xiang J; Xue T; Yang T; Liu L; Yan B
    BMC Cancer; 2022 Jun; 22(1):670. PubMed ID: 35715761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Computed Tomography-Based Radiomics Model to Predict Central Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma: A Multicenter Study.
    Li J; Wu X; Mao N; Zheng G; Zhang H; Mou Y; Jia C; Mi J; Song X
    Front Endocrinol (Lausanne); 2021; 12():741698. PubMed ID: 34745008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma.
    Li X; Xu C; Yu Y; Guo Y; Sun H
    BMC Cancer; 2021 Jul; 21(1):866. PubMed ID: 34320931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Usefulness of Machine Learning-Based Evaluation of Clinical and Pretreatment [
    Nakajo M; Kawaji K; Nagano H; Jinguji M; Mukai A; Kawabata H; Tani A; Hirahara D; Yamashita M; Yoshiura T
    Mol Imaging Biol; 2023 Apr; 25(2):303-313. PubMed ID: 35864282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
    Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
    Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting the effect of 5-fluorouracil-based adjuvant chemotherapy on colorectal cancer recurrence: A model using gene expression profiles.
    Chen Q; Gao P; Song Y; Huang X; Xiao Q; Chen X; Lv X; Wang Z
    Cancer Med; 2020 May; 9(9):3043-3056. PubMed ID: 32150672
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinoma.
    Sun MX; Zhao MJ; Zhao LH; Jiang HR; Duan YX; Li G
    Radiat Oncol; 2023 Apr; 18(1):67. PubMed ID: 37041545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach.
    Zhao J; He Y; Yang X; Tian P; Zeng L; Huang K; Zhao J; Zhou J; Zhu Y; Wang Q; Chen M; Li W; Gao Y; Zhang Y; Xia Y
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37730276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy.
    Liang L; Zhu J; Jia H; Huang L; Li D; Li Q; Li X
    Oncotarget; 2016 Jan; 7(1):1014-28. PubMed ID: 26510910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Franceschini D; Cozzi L; De Rose F; Navarria P; Fogliata A; Franzese C; Pezzulla D; Tomatis S; Reggiori G; Scorsetti M
    Strahlenther Onkol; 2020 Oct; 196(10):922-931. PubMed ID: 31722061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimizing the radiomics-machine-learning model based on non-contrast enhanced CT for the simplified risk categorization of thymic epithelial tumors: A large cohort retrospective study.
    Feng XL; Wang SZ; Chen HH; Huang YX; Xin YK; Zhang T; Cheng DL; Mao L; Li XL; Liu CX; Hu YC; Wang W; Cui GB; Nan HY
    Lung Cancer; 2022 Apr; 166():150-160. PubMed ID: 35287067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.